Roche looks to have a competitive GLP-1 drug

Off Biotech, biotechnology, Business, Congress, drug development, drug prices, drug pricing, FDA, finance, genetics, government agencies, Health, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, policy, Politics, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning. The weather here in Chicago has been super volatile. We’ve had thunderstorms the last few days, and last night I heard for the first time a tornado warning. Truly an ominous start to the week!

Read the rest…

Read Original Article: Roche looks to have a competitive GLP-1 drug »

About The Author